Skip to main content

Advertisement

Log in

Lessons from second- and third-generation parathyroid hormone assays in primary hyperparathyroidism

  • Opinion
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Jüppner H, Abou-Samra AB, Freeman M, et al. A G-protein coupled receptor for parathyroid hormone and parathyroid hormone-related peptide. Science 1991, 254: 1024–6.

    Article  PubMed  Google Scholar 

  2. National Kidney Foundation. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 2003, 42(suppl 3): S1–201.

    Google Scholar 

  3. Tannenbaum C, Clark J, Schwartzman K, et al. Yield of laboratory testing to identify secondary contributors to osteoporosis in otherwise healthy women. J Clin Endocrinol Metab 2002, 87: 4431–7.

    Article  PubMed  CAS  Google Scholar 

  4. Berson S, Yalow R. Immunochemical heterogeneity of parathyroid hormone in plasma. J Clin Endocrinol Metab 1968, 28: 1037–47.

    Article  PubMed  CAS  Google Scholar 

  5. Nussbaum S, Zahradnik R, Lavigne JR, et al. Highly sensitive two-site immunoradiometric assay of parathyrin, and its clinical utility in evaluating patients with hypercalcemia. Clin Chem 1987, 33: 1364–7.

    PubMed  CAS  Google Scholar 

  6. Blind E, Schmidt-Gayk H, Scharla S, et al. Two-site assay of intact parathyroid hormone in the investigation of primary hyperparathyroidism and other disorders of calcium metabolism compared with a mid-region assay. J Clin Endocrinol Metab 1988, 67: 353–60.

    Article  PubMed  CAS  Google Scholar 

  7. Endres DB, Villanueva R, Sharp CF Jr, Singer FR. Immunochemiluminometric and immunoradiometric determinations of intact and total immunoreactive parathyrin: performance in the differential diagnosis of hypercalcemia and hypoparathyroidism. Clin Chem 1991, 37: 162–8.

    PubMed  CAS  Google Scholar 

  8. Ratcliffe W, Heath DA, Ryan M, Jones SR. Performance and diagnostic application of a two-site immunometric assay for parathyrin in serum. Clin Chem 1989, 35: 1957–61.

    PubMed  CAS  Google Scholar 

  9. Michelangeli VP, Heyma P, Colman PG, Ebeling PR. Evaluation of a new, rapid and automated immunochemiluminometric assay for the measurement of serum intact parathyroid hormone. Ann Clin Biochem 1997, 34: 97–103.

    Article  PubMed  CAS  Google Scholar 

  10. Hemsen D, Franzson L, Hoffmann JP, et al. Multicenter evaluation of a new immunoassay for intact PTH measurement on the Elecsys system 2010 and 1010. Clin Lab 2002, 48: 131–41.

    Google Scholar 

  11. Lepage R, Roy L, Brossard JH, et al. A non-(1-84) circulating parathyroid hormone fragment interferes significantly with intact PTH commercial assay measurements in uremic samples. Clin Chem 1998, 44: 805–9.

    PubMed  CAS  Google Scholar 

  12. D’Amour P, Brossard JH, Rousseau L, et al. Structure of non-(1-84) PTH fragments secreted by parathyroid glands in primary and secondary hyperparathyroidism. Kidney Int 2005, 68: 998–1007.

    Article  PubMed  Google Scholar 

  13. John MR, Goodman WG, Gao P, Cantor TL, Salusky IB, Jüppner H. A novel immunoradiometric assay detects full-length human PTH but not amino-terminally truncated fragments: implication for PTH measurements in renal failure. J Clin Endocrinol Metab 1999, 84: 4287–90.

    Article  PubMed  CAS  Google Scholar 

  14. Gao P, Scheibel S, D’Amour P, et al. Development of a novel immunoradiometric assay exclusively for biologically active whole parathyroid hormone 1–84: implication for improvement of accurate assesment of parathyroid function. J Bone Miner Res 2001, 16: 605–14.

    Article  PubMed  CAS  Google Scholar 

  15. Inaba M, Nakatsuka K, Imanishi Y, et al. Technical and clinical characterization of the Bio-PTH (1-84) immunochemiluminometric assay and comparison with a second-generation assay for parathyroid hormone. Clin Chem 2004, 50: 385–90.

    Article  PubMed  CAS  Google Scholar 

  16. Friedman P. PTH revisited. Kidney Int Suppl 2004, (91): S13–9.

  17. Murray TM, Rao LG, Divieti P, Bringhurst FR. Parathyroid hormone secretion and action: evidence for discrete receptors for the carboxyl-terminal region and related biological action of carboxyl-terminal ligands. Endocr Rev 2005, 26: 78–113.

    Article  PubMed  CAS  Google Scholar 

  18. Bilezikian JP, Potts JT Jr, Fuleihan Gel-H, et al. Summary statement from a workshop on asymptomatic primary hyperparathyroidism: a perspective for the 21st century. J Clin Endocrinol Metab 2002, 87: 5353–61.

    Article  PubMed  CAS  Google Scholar 

  19. Glendenning P, Gutteridge DH, Retallack RW, Stuckey BG, Kermode DG, Kent GN. High prevalence of normal total calcium and intact PTH in 60 patients with proven primary hyperparathyroidism: a challenge to current diagnostic criteria. Aust N Z J Med 1998, 28: 173–8.

    PubMed  CAS  Google Scholar 

  20. Hollenberg AN, Arnold A. Hypercalcemia with low-normal serum intact PTH: a novel presentation of primary hyperparathyroidism. Am J Med 1991, 91: 547–8.

    Article  PubMed  CAS  Google Scholar 

  21. Souberbielle JC, Lawson-Body E, Hammadi B, Sarfati E, Kahan A, Cormier C. The use in clinical practice of parathyroid hormone normative values established in vitamin D-sufficient subjects. J Clin Endocrinol Metab 2003, 88: 3501–4.

    Article  PubMed  CAS  Google Scholar 

  22. Silverberg S, Bilezikian J. “Incipient” primary hyperparathyroidism: a “forme fruste” of an old disease. J Clin Endocrinol Metab 2003, 88: 5348–52.

    Article  PubMed  CAS  Google Scholar 

  23. Maruani G, Hertig A, Paillard M, Houillier P. Normocalcemic primary hyperpara-thyroidism: evidence for a generalized target-tissue resistance to parathyroid hormone. J Clin Endocrinol Metab 2003, 88: 4641–8.

    Article  PubMed  CAS  Google Scholar 

  24. Silverberg S, Gao P, Brown I, LoGerfo P, Cantor TL, Bilezikian JP. Clinical utility of an immunoradiometric assay for parathyroid hormone (1-84) in primary hyperparathyroidism. J Clin Endocrinol Metab 2003, 88: 4725–30.

    Article  PubMed  CAS  Google Scholar 

  25. Carnevale V, Dionisi S, Nofroni I, et al. Potential utility of a new IRMA for parathyroid hormone in postmenopausal patients with primary hyperparathyroidism. Clin Chem 2004, 50: 626–31.

    Article  PubMed  CAS  Google Scholar 

  26. Boudou P, Ibrahim F, Cormier C, Chabas A, Sarfati E, Souberbielle JC. Third- or second-generation PTH assays: a remaining debate in the diagnosis of primary hyperparathyroidism. J Clin Endocrinol Metab 2005, 90: 6370–2.

    Article  PubMed  CAS  Google Scholar 

  27. Koller H, Zitt E, Staudacher G, Neyer U, Mayer G, Rosenkranz AR. Variable parathyroid hormone (1-84)/carboxyl-terminal PTH ratios detected by 4 novel parathyroid hormone assays. Clin Nephrol 2003, 61: 337–43.

    Article  Google Scholar 

  28. Souberbielle JC, Boutten A, Carlier MC, et al. Inter-method variability in PTH measurement: implication for the care of CKD patients. Kidney Int 2006, 70: 345–50.

    Article  PubMed  CAS  Google Scholar 

  29. Cantor T, Yang Z, Caraiani N, Ilamathi E. Lack of comparability of intact parathyroid hormone measurements among commercial assays for end-stage renal disease patients: implication for treatment decisions. Clin Chem 2006, 52: 1771–6.

    Article  PubMed  CAS  Google Scholar 

  30. Souberbielle JC, Cormier C, Kindermans C, et al. Vitamin D status and redefining serum parathyroid hormone reference range in the elderly. J Clin Endocrinol Metab 2001, 86: 3086–90.

    PubMed  CAS  Google Scholar 

  31. Sahota O, Mundey MK, San P, Godber IM, Hosking DJ. Vitamin D insufficiency and the blunted PTH response in established osteoporosis: the role of magnesium deficiency. Osteoporos Int 2006, 17: 1013–21.

    Article  PubMed  CAS  Google Scholar 

  32. Bell NH, Greene A, Epstein S, Oexmann MJ, Shaw S, Shary JR. Evidence for alteration of the vitamin D-endocrine system in blacks. J Clin Invest 1985, 76: 470–3.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  33. Marcus R, Madvig P, Young G. Age-related changes in parathyroid hormone and parathyroid hormone action in normal humans. J Clin Endocrinol Metab 1984, 58: 223–30.

    Article  PubMed  CAS  Google Scholar 

  34. Boudou P, Ibrahim F, Cormier C, Sarfati E, Souberbielle JC. Unexpected serum parathyroid hormone profiles in some patients with primary hyperparathyroidism. Clin Chem 2006, 52: 757–60.

    Article  PubMed  CAS  Google Scholar 

  35. D’Amour P, Brossard JH, Rousseau L, Roy L, Gao P, Cantor T. Amino-terminal form of parathyroid hormone (PTH) with immunologic similarities to hPTH (1-84) is overproduced in primary and secondary hyperparathyroidism. Clin Chem 2003, 49: 2037–44.

    Article  PubMed  CAS  Google Scholar 

  36. Rabbani SA, Kremer R, Bennett HP, Goltzman D. Phosphorylation of parathyroid hormone by human and bovine parathyroid glands. J Biol Chem 1984, 259: 2949–55.

    PubMed  CAS  Google Scholar 

  37. Rubin M, D’Amour P, Cantor T, Bilezikian J, Silverberg S. A molecular form of PTH distinct from PTH (1-84) is produced in parathyroid carcinoima. J Bone Miner Res 2004, 19(suppl 1): S327.

    Google Scholar 

  38. Räkel A, Brossard JH, Patenaude JV, et al. Overproduction of an amino-terminal form of PTH distinct from human PTH(1-84) in a case of severe primary hyperparathyroidism: influence of medical treatment and surgery. Clinical Endocrinology (Oxf) 2005, 62: 721–7.

    Article  CAS  Google Scholar 

  39. Tanaka M, Itoh K, Matsushita K, Fujii H, Fukagawa M. Normalization of reversed bio-intact-PTH(1-84)/intact-PTH ratio after parathyroidectomy in a patient with severe secondary hyperparathyroidism. Clin Nephrol 2005, 64: 69–72.

    Article  PubMed  CAS  Google Scholar 

  40. Lafferty F, Hamlin C, Corrado K, Arnold A, Shuck J. Primary hyperparathyroidism with a low-normal atypical serum parathyroid hormone as shown by discordant immunoassay curves. J Clin Endocrinol Metab 2006, 1: 3826–9.

    Article  CAS  Google Scholar 

  41. Savoca R, Bock A, Kraenzlin M, Schmid H, Huber A. An automated “bio-intact” PTH assay: a step towards standardisation and improved correlation with parathyroid function in renal disease. Clin Chim Acta 2004, 343: 167–71.

    Article  PubMed  CAS  Google Scholar 

  42. Yamashita H, Gao P, Noguchi S, et al. Role of cyclase activating parathyroid hormone (1-84 PTH) measurements during parathyroid surgery: potential improvement of intraoperative PTH assay. Ann Surg 2002, 236: 105–11.

    Article  PubMed Central  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to J. C. Souberbielle.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Souberbielle, J.C., Boudou, P. & Cormier, C. Lessons from second- and third-generation parathyroid hormone assays in primary hyperparathyroidism. J Endocrinol Invest 31, 463–469 (2008). https://doi.org/10.1007/BF03346392

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03346392

Key-words

Navigation